receptor agonist. Ki
values are 13 and 0.71 nM for D2
respectively. Also has significant affinity for 5-HT1A
and adrenergic α2B
receptors. Exhibits antiparkinsonian acitivity.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.
Scheller et al.
N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease.
Belluzzi et al.
The citations listed below are publications that use Tocris products. Selected citations for Rotigotine hydrochloride include:
Showing Results 1 - 1 of 1